Archive - January 2020
MHRA updates Dysport license to include upper limb spasticity in children
Sandoz opens new UK HQ
Merck strengthens KRAS stake with Taiho and Astex partnership
Green Valley’s algae-based Alzheimer’s drug to undergo global clinical trials
Lynparza bags FDA approval for pancreatic cancer
AstraZeneca’s heart failure drug Farxiga scores FDA priority review
NICE rejects Akcea’s rare inherited disorder drug Waylivra
Here’s Why Perfumes, Cosmetics Are Not For Everyone